Heron Therapeutics reported a GAAP loss of $166.037 million for 9M 2021, up 0.6% from $164.997 million in the previous year. Revenues decreased by 3.4% to $65.691 million from $68.033 million a year earlier.
Heron Therapeutics reported a GAAP loss of $166.037 million for 9M 2021, up 0.6% from $164.997 million in the previous year. Revenues decreased by 3.4% to $65.691 million from $68.033 million a year earlier. 
ir.herontx.com
English (US) 